共 169 条
[1]
Ridruejo E(2020)The liver in times of COVID-19: what hepatologists should know Ann Hepatol 19 353-358
[2]
Soza A(2022)Human liver organoid derived intra-hepatic bile duct cells support SARS-CoV-2 infection and replication Sci Rep 12 5375-32
[3]
Lui VC(2021)Pathophysiological mechanisms of liver injury in COVID-19 Liver Int 41 20-2417
[4]
Hui KP(2022)COVID-19 and liver dysfunction: epidemiology, association and potential mechanisms Clin Res Hepatol Gastroenterol 46 101793-114
[5]
Babu RO(2015)Secondary sclerosing cholangitis in critically ill patients: clinical presentation, cholangiographic features, natural history, and outcome: a series of 16 cases Medicine (Baltimore) 94 e2188-1082
[6]
Nardo AD(2021)Secondary sclerosing cholangitis as cause of persistent jaundice in patients with severe COVID-19 Liver Int 41 2404-242
[7]
Schneeweiss-Gleixner M(2020)Secondary sclerosing cholangitis in critically ill patients: a rare disease precipitated by severe SARS-CoV-2 infection BMJ Case Rep 13 e237984-6
[8]
Bakail M(2020)Secondary sclerosing cholangitis in critically ill patients: an underdiagnosed entity GE Port J Gastroenterol 27 103-1425
[9]
Dixon ED(2021)Post-COVID-19 cholangiopathy: a novel entity Am J Gastroenterol 116 1077-2006
[10]
Lax SF(2021)A case of secondary sclerosing cholangitis due to COVID-19 Clin Imaging 80 239-1032